Amgen Inc. Stock-Based Compensation
Amgen Inc. (AMGN) reported Stock-Based Compensation of $240.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Amgen Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $165.00M, a 5.10% increase year-over-year.
- Amgen Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $75.00M, a 11.76% decline year-over-year.
- Amgen Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $125.00M, a 6.72% decline year-over-year.
- Amgen Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $127.00M, a 6.62% decline year-over-year.
- Amgen Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $494.00M, a 6.79% decline from fiscal 2024.
- Amgen Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $530.00M, a 22.97% increase from fiscal 2023.
- Amgen Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $431.00M, a 7.48% increase from fiscal 2022.
- Amgen Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $401.00M, a 17.60% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $165.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $240.00M 10-Q · filed 2026-08-05 | $365.00M derived: sum of 3 quarters · filed 2026-08-05 | $492.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $75.00M 10-Q · filed 2026-05-01 | $200.00M derived: sum of 2 quarters · filed 2026-05-01 | $327.00M derived: sum of 3 quarters · filed 2026-05-01 | $484.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $252.00M derived: sum of 2 quarters · filed 2026-02-13 | $409.00M derived: sum of 3 quarters · filed 2026-08-05 | $494.00M 10-K · filed 2026-02-13 |
| 2025-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $284.00M derived: sum of 2 quarters · filed 2026-08-05 | $369.00M 10-Q · filed 2025-11-05 | $503.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $157.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $242.00M 10-Q · filed 2026-08-05 | $376.00M derived: sum of 3 quarters · filed 2026-08-05 | $512.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $85.00M 10-Q · filed 2026-05-01 | $219.00M derived: sum of 2 quarters · filed 2026-05-01 | $355.00M derived: sum of 3 quarters · filed 2026-05-01 | $512.00M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $134.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $270.00M derived: sum of 2 quarters · filed 2026-02-13 | $427.00M derived: sum of 3 quarters · filed 2026-02-13 | $530.00M 10-K · filed 2026-02-13 |
| 2024-09-30 | $136.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $293.00M derived: sum of 2 quarters · filed 2025-11-05 | $396.00M 10-Q · filed 2025-11-05 | $557.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $157.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $260.00M 10-Q · filed 2025-08-06 | $421.00M derived: sum of 3 quarters · filed 2026-02-13 | $525.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $103.00M 10-Q · filed 2025-05-02 | $264.00M derived: sum of 2 quarters · filed 2026-02-13 | $368.00M derived: sum of 3 quarters · filed 2026-02-13 | $487.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $161.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $265.00M derived: sum of 2 quarters · filed 2026-02-13 | $384.00M derived: sum of 3 quarters · filed 2026-02-13 | $431.00M 10-K · filed 2026-02-13 |
| 2023-09-30 | $104.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $223.00M derived: sum of 2 quarters · filed 2024-10-31 | $270.00M 10-Q · filed 2024-10-31 | |
| 2023-06-30 | $119.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $166.00M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $47.00M 10-Q · filed 2024-05-03 | |||
| 2022-12-31 | $401.00M 10-K · filed 2025-02-14 | |||
| 2021-12-31 | $341.00M 10-K · filed 2024-02-14 | |||
| 2020-12-31 | $330.00M 10-K · filed 2023-02-09 | |||
| 2019-12-31 | $308.00M 10-K · filed 2022-02-16 | |||
| 2018-12-31 | $87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $164.00M derived: sum of 2 quarters · filed 2021-02-09 | $257.00M derived: sum of 3 quarters · filed 2021-02-09 | $311.00M 10-K · filed 2021-02-09 |
| 2018-09-30 | $77.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $170.00M derived: sum of 2 quarters · filed 2018-10-31 | $224.00M 10-Q · filed 2018-10-31 | $309.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $93.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $147.00M 10-Q · filed 2018-07-27 | $232.00M derived: sum of 3 quarters · filed 2020-02-12 | $320.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $54.00M 10-Q · filed 2018-04-25 | $139.00M derived: sum of 2 quarters · filed 2020-02-12 | $227.00M derived: sum of 3 quarters · filed 2020-02-12 | $323.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $85.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $173.00M derived: sum of 2 quarters · filed 2020-02-12 | $269.00M derived: sum of 3 quarters · filed 2020-02-12 | $329.00M 10-K · filed 2020-02-12 |
| 2017-09-30 | $88.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $184.00M derived: sum of 2 quarters · filed 2018-10-31 | $244.00M 10-Q · filed 2018-10-31 | $333.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $96.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $156.00M 10-Q · filed 2018-07-27 | $245.00M derived: sum of 3 quarters · filed 2019-02-13 | $328.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $60.00M 10-Q · filed 2018-04-25 | $149.00M derived: sum of 2 quarters · filed 2019-02-13 | $232.00M derived: sum of 3 quarters · filed 2019-02-13 | $319.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $89.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $172.00M derived: sum of 2 quarters · filed 2019-02-13 | $259.00M derived: sum of 3 quarters · filed 2019-02-13 | $311.00M 10-K · filed 2019-02-13 |
| 2016-09-30 | $83.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $170.00M derived: sum of 2 quarters · filed 2017-10-26 | $222.00M 10-Q · filed 2017-10-26 | $302.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $87.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $139.00M 10-Q · filed 2017-07-26 | $219.00M derived: sum of 3 quarters · filed 2018-02-13 | $301.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $52.00M 10-Q · filed 2017-04-27 | $132.00M derived: sum of 2 quarters · filed 2018-02-13 | $214.00M derived: sum of 3 quarters · filed 2018-02-13 | $304.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $162.00M derived: sum of 2 quarters · filed 2018-02-13 | $252.00M derived: sum of 3 quarters · filed 2018-02-13 | $322.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $172.00M derived: sum of 2 quarters · filed 2016-10-28 | $242.00M 10-Q · filed 2016-10-28 | $348.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $90.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $160.00M 10-Q · filed 2016-07-29 | $266.00M derived: sum of 3 quarters · filed 2017-02-14 | $369.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $70.00M 10-Q · filed 2016-05-02 | $176.00M derived: sum of 2 quarters · filed 2017-02-14 | $279.00M derived: sum of 3 quarters · filed 2017-02-14 | $391.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $106.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $209.00M derived: sum of 2 quarters · filed 2017-02-14 | $321.00M derived: sum of 3 quarters · filed 2017-02-14 | $408.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | $103.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $215.00M derived: sum of 2 quarters · filed 2015-11-02 | $302.00M 10-Q · filed 2015-11-02 | $401.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $112.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $199.00M 10-Q · filed 2015-08-05 | $298.00M derived: sum of 3 quarters · filed 2016-10-31 | $398.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $87.00M 10-Q · filed 2015-04-27 | $186.00M derived: sum of 2 quarters · filed 2016-10-31 | $286.00M derived: sum of 3 quarters · filed 2016-10-31 | $398.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $99.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $199.00M derived: sum of 2 quarters · filed 2016-10-31 | $311.00M derived: sum of 3 quarters · filed 2016-10-31 | $403.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | $100.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $212.00M derived: sum of 2 quarters · filed 2014-10-29 | $304.00M 10-Q · filed 2014-10-29 | $395.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $112.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $204.00M 10-Q · filed 2014-08-05 | $295.00M derived: sum of 3 quarters · filed 2015-02-19 | $386.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $92.00M 10-Q · filed 2014-04-30 | $183.00M derived: sum of 2 quarters · filed 2015-02-19 | $274.00M derived: sum of 3 quarters · filed 2015-02-19 | $379.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $91.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $182.00M derived: sum of 2 quarters · filed 2015-02-19 | $287.00M derived: sum of 3 quarters · filed 2015-02-19 | $362.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | $91.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $196.00M derived: sum of 2 quarters · filed 2013-10-29 | $271.00M 10-Q · filed 2013-10-29 | $367.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $105.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $180.00M 10-Q · filed 2013-08-06 | $276.00M derived: sum of 3 quarters · filed 2014-02-24 | $347.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $75.00M 10-Q · filed 2013-05-03 | $171.00M derived: sum of 2 quarters · filed 2014-02-24 | $242.00M derived: sum of 3 quarters · filed 2014-02-24 | $339.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $96.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $167.00M derived: sum of 2 quarters · filed 2014-02-24 | $264.00M derived: sum of 3 quarters · filed 2014-02-24 | $341.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | $71.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $168.00M derived: sum of 2 quarters · filed 2012-11-06 | $245.00M 10-Q · filed 2012-11-06 | $350.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $97.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $174.00M 10-Q · filed 2012-08-08 | $279.00M derived: sum of 3 quarters · filed 2013-02-27 | $361.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $77.00M 10-Q · filed 2012-05-08 | $182.00M derived: sum of 2 quarters · filed 2013-02-27 | $264.00M derived: sum of 3 quarters · filed 2013-02-27 | $362.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $105.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $187.00M derived: sum of 2 quarters · filed 2013-02-27 | $285.00M derived: sum of 3 quarters · filed 2013-02-27 | $353.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $82.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $180.00M derived: sum of 2 quarters · filed 2011-11-04 | $248.00M 10-Q · filed 2011-11-04 | $323.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $98.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $166.00M 10-Q · filed 2011-08-08 | $241.00M derived: sum of 3 quarters · filed 2012-02-29 | $327.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $68.00M 10-Q · filed 2011-05-10 | $143.00M derived: sum of 2 quarters · filed 2012-02-29 | $229.00M derived: sum of 3 quarters · filed 2012-02-29 | $293.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $75.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $161.00M derived: sum of 2 quarters · filed 2012-02-29 | $225.00M derived: sum of 3 quarters · filed 2012-02-29 | $284.00M 10-K · filed 2012-02-29 |
| 2009-09-30 | $86.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $150.00M derived: sum of 2 quarters · filed 2010-11-08 | $209.00M 10-Q · filed 2010-11-08 | $276.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $123.00M 10-Q · filed 2010-08-09 | $190.00M derived: sum of 3 quarters · filed 2011-02-25 | $252.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-31 | $59.00M 10-Q · filed 2010-05-07 | $126.00M derived: sum of 2 quarters · filed 2011-02-25 | $188.00M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-31 | $67.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $129.00M derived: sum of 2 quarters · filed 2011-02-25 | $262.00M 10-K · filed 2011-02-25 | |
| 2008-09-30 | $62.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | $195.00M 10-Q · filed 2009-11-06 | ||
| 2008-06-30 | $133.00M 10-Q · filed 2009-08-10 | |||
| 2007-12-31 | $263.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |